European Journal of Cancer
Volume 42, Issue 12 , Pages 1875-1880, August 2006

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus

  • I. Duran

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • ,
  • L.L. Siu

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • Corresponding Author InformationCorresponding author: Tel.: +1 416 946 2911; fax: +1 416 946 4467.
    • ,
  • A.M. Oza

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • ,
  • T.-B. Chung

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Diagnostic Imaging, Toronto, Canada
    • ,
  • J. Sturgeon

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • ,
  • C.A. Townsley

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • ,
  • G.R. Pond

      Affiliations

    • Princess Margaret Hospital, University Health Network, Department of Medical Oncology and Haematology, 610 University Avenue, Suite 5-718, Toronto, Ont., Canada M5G 2M9
    • ,
  • L. Seymour

      Affiliations

    • National Cancer Institute of Canada Clinical Trials Group, Kingston, Canada
    • ,
  • M. Niroumand

      Affiliations

    • Mount Sinai Hospital, Department of Respirology, Toronto, Canada

Received 9 November 2005; received in revised form 17 March 2006; accepted 21 March 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0959-8049(06)00354-6

doi:10.1016/j.ejca.2006.03.015

European Journal of Cancer
Volume 42, Issue 12 , Pages 1875-1880, August 2006

Article Tools

* Image Usage & Resolution